Effect of the diet type and temperature on the C. elegans transcriptome
Effect of the diet type and temperature on the C. elegans transcriptome |
|
https://doi.org/10.18632/oncotarget.23563
Eva Gomez-Orte,
Eric Cornes,
Angelina Zheleva,
Beatriz Sáenz-Narciso,
María de Toro,
María Iñiguez,
Rosario Lopez,
Juan-Félix San-Juan,
Begoña Ezcurra,
Begoña Sacristán,
Adolfo Sánchez-Blanco,
Julián Cerón,
and Juan Cabello
|
| 9556-9571 |
Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes
Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes |
|
https://doi.org/10.18632/oncotarget.23851
Xiaomei Wang,
Anna Malawista,
Feng Qian,
Christine Ramsey,
Heather G. Allore,
and Ruth R. Montgomery
|
| 9572-9580 |
CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans
CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in C. elegans |
|
https://doi.org/10.18632/oncotarget.24039
Yujie Li,
Sandra Finkbeiner,
Athina Ganner,
Julia Gerber,
Marinella Klein,
Manuel Grafe,
Jakob Kandzia,
Antje Thien,
Kathrin Thedieck,
Gerhard Breves,
Thomas Jank,
Ralf Baumeister,
Gerd Walz,
and Elke Neumann- Haefelin
|
| 9581-9595 |
Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity
Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity |
|
https://doi.org/10.18632/oncotarget.24073
Xiaofeng Liu,
Mi Zhou,
Yanling Yang,
Jing wu,
and Qisheng Peng
|
| 9596-9607 |
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents |
|
https://doi.org/10.18632/oncotarget.20033
Jean Davidson,
Zhewei Shen,
Xue Gong,
and Jonathan R. Pollack
|
| 9608-9617 |
Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage
Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage |
|
https://doi.org/10.18632/oncotarget.22709
Macarena Guijo,
María Ceballos-Chávez,
Elena Gómez-Marín,
Laura Basurto-Cayuela,
and José C. Reyes
|
| 9618-9631 |
NFAT-mediated defects in erythropoiesis cause anemia in Il2−/− mice
NFAT-mediated defects in erythropoiesis cause anemia in Il2−/− mice |
|
https://doi.org/10.18632/oncotarget.23745
Sabrina Giampaolo,
Gabriela Wójcik,
Stefan Klein-Hessling,
Edgar Serfling,
and Amiya K. Patra
|
| 9632-9644 |
Molecular characterization of breast cancer cell response to metabolic drugs
Molecular characterization of breast cancer cell response to metabolic drugs |
|
https://doi.org/10.18632/oncotarget.24047
Lucía Trilla-Fuertes,
Angelo Gámez-Pozo,
Jorge M. Arevalillo,
Mariana Díaz-Almirón,
Guillermo Prado-Vázquez,
Andrea Zapater-Moros,
Hilario Navarro,
Rosa Aras-López,
Irene Dapía,
Rocío López-Vacas,
Paolo Nanni,
Sara Llorente-Armijo,
Pedro Arias,
Alberto M. Borobia,
Paloma Maín,
Jaime Feliú,
Enrique Espinosa,
and Juan Ángel Fresno Vara
|
| 9645-9660 |
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression |
|
https://doi.org/10.18632/oncotarget.23800
Domenico Trombetta,
Paolo Graziano,
Aldo Scarpa,
Angelo Sparaneo,
Guilio Rossi,
Antonio Rossi,
Massimo Di Maio,
Davide Antonello,
Andrea Mafficini,
Federico Pio Fabrizio,
Maria Carmina Manzorra,
Teresa Balsamo,
Flavia Centra,
Michele Simbolo,
Angela Pantalone,
Michela Notarangelo,
Paola Parente,
Maria Cecilia Lucia Dimitri,
Antonio Bonfitto,
Fabiola Fiordelisi,
Clelia Tiziana Storlazzi,
Alberto L'Abbate,
Marco Taurchini,
Evaristo Maiello,
Vito Michele Fazio,
and Lucia Anna Muscarella
|
| 9661-9671 |
TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer |
|
https://doi.org/10.18632/oncotarget.23822
Rosana D. Meyer,
Xueqing Zou,
Marwa Ali,
Esma Ersoy,
Philip Apraku Bondzie,
Mehrdad Lavaei,
Ilya Alexandrov,
Joel Henderson,
and Nader Rahimi
|
| 9672-9684 |
Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation
Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation |
|
https://doi.org/10.18632/oncotarget.23859
Miriam Buttacavoli,
Nadia Ninfa Albanese,
Gianluca Di Cara,
Rosa Alduina,
Claudia Faleri,
Michele Gallo,
Giuseppe Pizzolanti,
Giuseppe Gallo,
Salvatore Feo,
Franco Baldi,
and Patrizia Cancemi
|
| 9685-9705 |
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.23880
Bhavani Gopalakrishnan,
Carolyn Cheney,
Rajeswaran Mani,
Xiaokui Mo,
Donna Bucci,
Alison Walker,
Rebecca Klisovic,
Bhavana Bhatnagar,
Katherine Walsh,
Bjorn Rueter,
Irene Waizenegger,
Karl-Heinz Heider,
William Blum,
Sumithira Vasu,
and Natarajan Muthusamy
|
| 9706-9713 |
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms |
|
https://doi.org/10.18632/oncotarget.23882
Guillermo Montalban-Bravo,
Koichi Takahashi,
Keyur Patel,
Feng Wang,
Song Xingzhi,
Graciela M. Nogueras,
Xuelin Huang,
Ana Alfonso Pierola,
Elias Jabbour,
Simona Colla,
Irene Gañan-Gomez,
Gautham Borthakur,
Naval Daver,
Zeev Estrov,
Tapan Kadia,
Naveen Pemmaraju,
Farhad Ravandi,
Carlos Bueso-Ramos,
Ali Chamseddine,
Marina Konopleva,
Jianhua Zhang,
Hagop Kantarjian,
Andrew Futreal,
and Guillermo Garcia-Manero
|
| 9714-9727 |
Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype
Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype |
|
https://doi.org/10.18632/oncotarget.23887
Karolina Gołąb,
Randall Grose,
Veronica Placencia,
Amittha Wickrema,
Julia Solomina,
Martin Tibudan,
Evelyn Konsur,
Kamil Ciepły,
Natalia Marek- Trzonkowska,
Piotr Trzonkowski,
J. Michael Millis,
John Fung,
and Piotr Witkowski
|
| 9728-9740 |
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers |
|
https://doi.org/10.18632/oncotarget.24188
Luc Cabel,
Alina Fuerea,
Ludovic Lacroix,
Capucine Baldini,
Patricia Martin,
Antoine Hollebecque,
Sophie Postel-Vinay,
Andrea Varga,
Rastilav Balheda,
Anas Gazzah,
Jean-Marie Michot,
Aurélien Marabelle,
Etienne Rouleau,
Eric Solary,
Thierry De Baere,
Eric Angevin,
Jean-Pierre Armand,
Stefan Michiels,
Jean Yves Scoazec,
Samy Ammari,
Fabrice André,
Jean-Charles Soria,
Christophe Massard,
and Loic Verlingue
|
| 9741-9750 |
CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer
CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24231
Rosa Mistica C. Ignacio,
Yuan-Lin Dong,
Syeda M. Kabir,
Hyeongjwa Choi,
Eun-Sook Lee,
Andrew J. Wilson,
Alicia Beeghly-Fadiel,
Margaret M. Whalen,
and Deok-Soo Son
|
| 9751-9765 |
Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy |
|
https://doi.org/10.18632/oncotarget.23919
Giuseppe Gritti,
Andrea Gianatti,
Fiorella Petronzelli,
Rita De Santis,
Chiara Pavoni,
Riccardo Lorenzo Rossi,
Laura Cattaneo,
Luigi Giusto Spagnoli,
Silvia Ferrari,
Andrea Rossi,
Anna Maria Barbui,
and Alessandro Rambaldi
|
| 9766-9775 |
Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model
Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model |
|
https://doi.org/10.18632/oncotarget.24267
Sanghoon Lee,
Tishi Shah,
Changhong Yin,
Jessica Hochberg,
Janet Ayello,
Erin Morris,
Carmella van de Ven,
and Mitchell S. Cairo
|
| 9776-9788 |
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.23929
Dingyuan Hu,
Daniel Ansari,
Krzysztof Pawłowski,
Qimin Zhou,
Agata Sasor,
Charlotte Welinder,
Theresa Kristl,
Monika Bauden,
Melinda Rezeli,
Yi Jiang,
György Marko-Varga,
and Roland Andersson
|
| 9789-9807 |
The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells
The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells |
|
https://doi.org/10.18632/oncotarget.24275
Harrison T. Supnick,
Rodica P. Bunaciu,
and Andrew Yen
|
| 9808-9824 |
Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients
Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients |
|
https://doi.org/10.18632/oncotarget.23934
Meng-Hua Lee,
Joseph Tung-Chieh Chang,
Chun-Ta Liao,
Ya-Shan Chen,
Ming-Ling Kuo,
and Chia-Rui Shen
|
| 9825-9837 |
Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells
Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells |
|
https://doi.org/10.18632/oncotarget.24305
Moritz Horn,
Virginia Kroef,
Kira Allmeroth,
Nicole Schuller,
Stephan Miethe,
Martin Peifer,
Josef M. Penninger,
Ulrich Elling,
and Martin S. Denzel
|
| 9838-9851 |
Prominent role of RAB39A-RXRB axis in cancer development and stemness
Prominent role of RAB39A-RXRB axis in cancer development and stemness |
|
https://doi.org/10.18632/oncotarget.23955
Tokuhiro Chano,
Hiroko Kita,
Sofia Avnet,
Silvia Lemma,
and Nicola Baldini
|
| 9852-9866 |
Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid
Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid |
|
https://doi.org/10.18632/oncotarget.23984
Birthe Heitkötter,
Konrad Steinestel,
Marcel Trautmann,
Inga Grünewald,
Peter Barth,
Heidrun Gevensleben,
Martin Bögemann,
Eva Wardelmann,
Wolfgang Hartmann,
Kambiz Rahbar,
and Sebastian Huss
|
| 9867-9874 |
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases |
|
https://doi.org/10.18632/oncotarget.23986
Cristina Romei,
Raffaele Ciampi,
Francesca Casella,
Alessia Tacito,
Liborio Torregrossa,
Clara Ugolini,
Fulvio Basolo,
Gabriele Materazzi,
Paolo Vitti,
and Rossella Elisei
|
| 9875-9884 |
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.24009
Céléna Dubuc,
Martin Savard,
Veronica Bovenzi,
Andrée Lessard,
Audrey Fortier,
Jérôme Côté,
Witold Neugebauer,
Flavio Rizzolio,
Sameh Geha,
Antonio Giordano,
Sylvain Chemtob,
and Fernand Gobeil
|
| 9885-9906 |
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.24035
Sumati Gupta,
Kelly Doyle,
Timothy L. Mosbruger,
Andrew Butterfield,
Alexis Weston,
Allison Ast,
Mohan Kaadige,
Anupam Verma,
and Sunil Sharma
|
| 9907-9924 |
Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice |
|
https://doi.org/10.18632/oncotarget.24066
Shoji Yamada,
Yoko Takashina,
Mitsuhiro Watanabe,
Ryogo Nagamine,
Yoshimasa Saito,
Nobuhiko Kamada,
and Hidetsugu Saito
|
| 9925-9939 |
CXCR4: A new player in vestibular schwannoma pathogenesis
CXCR4: A new player in vestibular schwannoma pathogenesis |
|
https://doi.org/10.18632/oncotarget.24119
Maria Breun,
Alexandra Schwerdtfeger,
Donato Daniel Martellotta,
Almuth F. Kessler,
Jose M. Perez,
Camelia M Monoranu,
Ralf-Ingo Ernestus,
Cordula Matthies,
Mario Löhr,
and Carsten Hagemann
|
| 9940-9950 |
Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation
Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation |
|
https://doi.org/10.18632/oncotarget.24131
Hyun-Kyung Kim,
Purevjargal Naidansuren,
Seung Woo Lee,
Rae-Kwon Kim,
Su-Jae Lee,
Suk Keun Lee,
Yong-Kil Hong,
and Young Ae Joe
|
| 9951-9962 |
HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway |
|
https://doi.org/10.18632/oncotarget.24133
Xi Xu,
Yunfeng Wang,
Hong Deng,
Chungang Liu,
Jingjing Wu,
and Maode Lai
|
| 9963-9974 |
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits |
|
https://doi.org/10.18632/oncotarget.24160
Takashi Yoshida,
Masaki Ri,
Takashi Kanamori,
Sho Aoki,
Reham Ashour,
Shiori Kinoshita,
Tomoko Narita,
Haruhito Totani,
Ayako Masaki,
Asahi Ito,
Shigeru Kusumoto,
Takashi Ishida,
Hirokazu Komatsu,
Shun Kitahata,
Takuya Chiba,
Satoshi Ichikawa,
and Shinsuke Iida
|
| 9975-9991 |
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.24173
Yanming Jiang,
Song Qu,
Xinbin Pan,
Shiting Huang,
and Xiaodong Zhu
|
| 9992-10004 |
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study |
|
https://doi.org/10.18632/oncotarget.24234
Stéphane Supiot,
Caroline Rousseau,
Mélanie Dore,
Catherine Cheze-Le-Rest,
Christine Kandel-Aznar,
Vincent Potiron,
Stéphane Guerif,
François Paris,
Ludovic Ferrer,
Loïc Campion,
Philippe Meingan,
Gregory Delpon,
Matthieu Hatt,
and Dimitris Visvikis
|
| 10005-10015 |
Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell
Effect of traumatic brain injury on nicotine-induced modulation of dopamine release in the striatum and nucleus accumbens shell |
|
https://doi.org/10.18632/oncotarget.24245
Yuan-Hao Chen,
Tung-Tai Kuo,
Eagle Yi-Kung Huang,
Yu-Ching Chou,
Yung-Hsiao Chiang,
Barry J. Hoffer,
and Jonathon Miller
|
| 10016-10028 |
CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells
CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells |
|
https://doi.org/10.18632/oncotarget.24252
Hiroaki Miyazaki,
Ryou-u Takahashi,
Marta Prieto-Vila,
Yumi Kawamura,
Seiji Kondo,
Tatsuo Shirota,
and Takahiro Ochiya
|
| 10029-10041 |
Mutational landscape of radiation-associated angiosarcoma of the breast
Mutational landscape of radiation-associated angiosarcoma of the breast |
|
https://doi.org/10.18632/oncotarget.24273
Bryan J. Thibodeau,
Vincent Lavergne,
Nayana Dekhne,
Pamela Benitez,
Mitual Amin,
Samreen Ahmed,
Jean L. Nakamura,
Philip R. Davidson,
Alice O. Nakamura,
Inga S. Grills,
Peter Y. Chen,
Jessica Wobb,
and George D. Wilson
|
| 10042-10053 |
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.24300
Nataliya Rohr-Udilova,
Eva Bauer,
Gerald Timelthaler,
Robert Eferl,
Klaus Stolze,
Matthias Pinter,
Martha Seif,
Hubert Hayden,
Thomas Reiberger,
Rolf Schulte-Hermann,
Markus Peck-Radosavljevic,
Dagmar Stoiber,
and Michael Trauner
|
| 10054-10068 |
Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain |
|
https://doi.org/10.18632/oncotarget.24311
Anna Kovalchuk,
Yaroslav Ilnytskyy,
Rafal Woycicki,
Rocio Rodriguez-Juarez,
Gerlinde A.S. Metz,
and Olga Kovalchuk
|
| 10069-10082 |
Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis |
|
https://doi.org/10.18632/oncotarget.23394
Yong Ding,
Hai-Feng Lian,
and Yaowu Du
|
| 10083-10090 |
Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications
Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications |
|
https://doi.org/10.18632/oncotarget.23497
Dong Ni,
Xin Ma,
Hong-Zhao Li,
Yu Gao,
Xin-Tao Li,
Yu Zhang,
Qing Ai,
Qing-Bo Huang,
Jun-Yao Duan,
and Xu Zhang
|
| 10091-10099 |
Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer
Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer |
|
https://doi.org/10.18632/oncotarget.24071
Yingqiu Song,
Beth Erickson,
Xiaojian Chen,
Guiling Li,
Gang Wu,
Eric Paulson,
Paul Knechtges,
and Li X. Allen
|
| 10100-10109 |
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer |
|
https://doi.org/10.18632/oncotarget.24118
Hatem Soliman,
Fatema Khambati,
Hyo S. Han,
Roohi Ismail-Khan,
Marilyn M. Bui,
Daniel M. Sullivan,
and Scott Antonia
|
| 10110-10117 |
Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients
Prognostic significance of the red blood cell distribution width that maintain at high level following completion of first line therapy in mutiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.24076
Zhouxiang Jin,
Shujuan Zhou,
Haige Ye,
Songfu Jiang,
Kang Yu,
and Yang Ji
|
| 10118-10127 |
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.24176
Hinrich Wieder,
Ambros J. Beer,
Jens Siveke,
Tibor Schuster,
Andreas K. Buck,
Ken Herrmann,
and Jens C. Stollfuss
|
| 10128-10134 |
Metformin and berberine, two versatile drugs in treatment of common metabolic diseases
Metformin and berberine, two versatile drugs in treatment of common metabolic diseases |
|
https://doi.org/10.18632/oncotarget.20807
Haoran Wang,
Chen Zhu,
Ying Ying,
Lingyu Luo,
Deqiang Huang,
and Zhijun Luo
|
| 10135-10146 |
Newly developed anti-angiogenic therapy in non-small cell lung cancer
Newly developed anti-angiogenic therapy in non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.23755
Jingjing Qu,
Yongchang Zhang,
Xue Chen,
Haiyan Yang,
Chunhua Zhou,
and Nong Yang
|
| 10147-10163 |
The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer
The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer |
|
https://doi.org/10.18632/oncotarget.24309
Chiranjib Chakraborty,
Ashish Ranjan Sharma,
Garima Sharma,
Bimal Kumar Sarkar,
and Sang-Soo Lee
|
| 10164-10174 |
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression |
|
https://doi.org/10.18632/oncotarget.23699
Gregorio J. Petrirena,
Julien Masliah-Planchon,
Quentin Sala,
Bertrand Pourroy,
Didier Frappaz,
Emeline Tabouret,
Thomas Graillon,
Jean-Claude Gentet,
Olivier Delattre,
Olivier Chinot,
and Laetitia Padovani
|
| 10175-10183 |
Correction: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy
Correction: Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy |
|
https://doi.org/10.18632/oncotarget.24463
Sheng-Chieh Chan,
Nai-Ming Cheng,
Chia-Hsun Hsieh,
Shu-Hang Ng,
Chien-Yu Lin,
Tzu-Chen Yen,
Cheng-Lung Hsu,
Hung-Ming Wan,
Chun-Ta Liao,
Kai-Ping Chang,
and Jiun-Jie Wang
|
| 10184-10184 |
